Liver (for PBR 2) Flashcards
(106 cards)
Term used for transient enhancement differences seen during either arterial phase imaging or portal venous imaging on MDCT or dynamic MRI
Transient hepatic attenuation differences (THAD) or
Transient hepatic intensity differences (THID) or
Transient hepatic enhancement differences (THED)
Findings in hepatic perfusion abnormalities
- Hyperenhancement in the arterial phase
- Isoenhancement in portal venous and delayed phase
- Isoattenuation on unenhanced CT
- Isointensity on MR unenhanced T1, T2, and DWI
Evidence of hepatomegaly
Round of the inferior border of the liver
Extension of the right lobe of the liver inferior to the lower pole of the right kidney
Liver length of how many centimeters is considered enlarged?
Greater than 15.5 cm
Measures in the midclavicular line
It is an elongated inferior tip of the right lobe of the liver
Reidel lobe
Normal variant - when present the left lobe of the liver is correspondingly smaller in size
Most common abnormality by hepatic imaging
Hepatic steatosis
Two most common cause of hepatic steatosis
Alcoholic liver disease
Nonalcoholic fatty liver related to metabolic syndrome
Reliable ultrasound finding of nonalcoholic steatohepatitis (NASH)
- Liver echogenicity is greater than the renal cortex
- Loss of visualization of normal echogenic portal triads
- Poor sound penetration with loss of definition of diaphragm
All three findings must be present to make an unquivocal US diagnosis
Unenhanced CT finding of NASH
- Liver attenuation is 10 HU less than spleen attenuation
OR
Liver attenuation is less than 40 HU - Blood vessels appear brighter than the dark liver on unenhanced CT
Sign seen with fatty liver being dark on unenhanced CT and bright on US
“Flip-flop” sign
Characteristic feature of fatty deposition on all modalities
- Lack of mass effect (no bulging of the liver contour or displacement of intrahepatic vessels)
- Angulated geometric boundaries between involved and uninvolved parenchyma
Most common pattern of fatty liver
a. Diffuse fatty liver
b. Focal fatty liver
c. Focal sparing
d. Multifocal fatty liver
e. Perivascular fatty liver
f. Subcapsular fatty liver
A. Diffuse fatty liver
MC locations of focal fat
Adjacent to the:
Falciform ligament
Gallbladder fossa
Porta hepatis
MC location of fat-spared area in fatty liver
Segment 4
Pattern of fatty liver which is only seen in patients with renal failure on peritoneal dialysis and only when insulin is added to the dialysate
Subcapsular fatty liver
High concentrations of insulin in the subcapsular lier lead to fat deposition
Liver disease that is characterized pathologically by:
- Diffuse parenchymal destruction
- Fibrosis with alteration of hepatic architecture
- Innumerable regenerative nodules (RN) that replace normal liver parenchyma
Cirrhosis
Imaging findings of cirrhosis (7)
- Hepatomegaly (early)
- Atrophy or hypertrophy of hepatic segments
- Coarsening of hepatic parenchymal texture
- Nodularity of the parenchyma, often most noticeable on the liver surface
- Hypertrophy of the caudate lobe and left lobe with shrinkage of the right lobe
- Regenerating nodules
- Enlargement of the hilar periportal space (>10mm)
Creator's notes: Early enlargement Atrophy Coarsening Nodularity Caudate lobe hypertrophy Enlargement of the hilar periportal space (1 cm)
Imaging finding of cirrhosis that reflects parenchymal atrophy
Enlargement of the hilar periportal space
Extrahepatic signs of cirrhosis
- Portosystemic collaterals (as evidence of portal hypertension)
- Splenomegaly
- Ascites
Different causes of nodules in a cirrhotic liver
- Regenerative nodules
- Dysplastic nodules
- Hepatocellular carcinoma
- Confluent fibrosis
- Focal fat infiltration
- Focal fat sparing
- Metastases (rare in cirrhosis)
Most common nodules of cirrhosis
Regenerative nodules
Regular pathologic feature of cirrhosis due to attempted repair of hepatocyte injury
Difference of low-grade dysplastic nodules and high-grade dysplastic nodules
Low-grade DN
- Minimal atypia, no mitosis, not premalignant
- Supplied by portain vein
- No arterial phase enhancement
- Progresses to high-grade
High-grade DN
- Moderate atypia, occasional mitosis, secrete AFP
- Not frankly malignant
- Blood supply by hepatic artery
- Show arterial phase enhancement
Siderotic nodules may be regenerative or dysplastic but are seldom benign.
What imaging finding would consider a benign siderotic nodule on MRI?
< 20 mm
Homogeneous on all sequences (low signal)
Isoenhance compared to background cirrhotic nodules in all phases
Major criteria for diagnosis of hepatocellular carcinoma (LIRADS)
- Hyperenhancement in arterial phase definitely greater than background liver
- “Washout”
- Threshold growth